Subha Madhavan @subhamadhavan

Precision Medicine & Digital Health Leader, Data scientist, Great boss award, Force multiplier, Service to America award, Startup & NonProfit Board Governance icbi.georgetown.edu/page.php?ID=Ma… Georgetown University Joined October 2009

Tweets

2K
Followers

1K
Following

1K
Likes

3K

Subha Madhavan @subhamadhavan

3 years ago

@NLMdirector Thank you for your leadership and vision that has touched so many. Excited for your next phase. Cheers!

0 0 3 145 0

View Details

Subha Madhavan @subhamadhavan

4 years ago

#ASCO22 excited to reconnect with these two amazing breast cancer leaders @DrLauraEsserman @claudine_isaacs

0 0 6 0 1

View Details

Subha Madhavan @subhamadhavan

4 years ago

Super excited about this panel with @TClozel @NCIJBSloan Jim Chen and @ihuerga at #BioIT22 next week. Join us in person or virtually to discuss how #AI is transforming #oncology R&D and care delivery. bio-itworldexpo.com

0 2 8 0 0

View Details

Cindy Crowninshield @C_Crowninshield

4 years ago

Leading experts discuss applications, pitfalls, and future directions for applications of AI in oncology in the AI for Oncology, Precision Medicine, and Health track @ Bio-IT this May! bio-itworldexpo.com/?utm_medium=so… #BioIT22 @bioitworld #medicine #research #health #ai @subhamadhavan

0 2 2 0 0

View Details

Subha Madhavan @subhamadhavan

4 years ago

Thrilled to see this work on standardized evidence for evaluating NTRK fusions in patients published with amazing co-authors #precisiononcology #DataScience #evidencebasedmedicine

Alanna Church, MD @AlannaChurch_MD

4 years ago

Important features when evaluating a potentially oncogenic fusion like LMNA-NTRK1: ✅stranding and directionality ✅ kinase domain preserved ✅ in-frame sciencedirect.com/science/articl…

0 3 21 0 4

0 0 3 0 1

View Details

Daniel Kraft, MD @daniel_kraft

4 years ago

#DigitalHealth COVID-19 Impact Assessment: Lessons Learned and Compelling Needs In @theNAMedicine by @peteratmsr, @dramyabernethy , @DShaywitz, Adi Gundlapalli, Jim Weinstein, P. Murali Doraiswamy, @kevin_schulman, & @subhamadhavan nam.edu/digital-health…

0 2 6 0 0

View Details

Subha Madhavan @subhamadhavan

5 years ago

@embimd @IBJnews @Regenstrief You are indeed a super hero Peter! very well deserved.

1 0 1 0 0

View Details

Cancer Genomics Consortium (CGC) @CG_Consortium

5 years ago

Invited Speaker @subhamadhavan presented incredibly innovative work at #CGCAnnual2021 using #AI, #NLP, and expert crowdsourcing approaches to enable precision medicine, match patients to trials, automatically identify adverse events, and standardize curation of somatic variants.

0 2 8 0 0

View Details

Subha Madhavan @subhamadhavan

5 years ago

Presentation by @DespinaKontos from @PennMedicine at #ASCO21 where her team applies #machinelearning to radiomics, clinical and molecular features to develop treatment plans for cancer patients. New approaches with #datascience #digitalhealth for #cancercare

0 4 5 0 1

View Details

Subha Madhavan @subhamadhavan

5 years ago

Terrific graphic that highlights differences between lung and breast clinical communities in terms of uptake of precision medicines. #ASCO21’s theme of access to (right) care is clearly important.

Stephen V Liu, MD @StephenVLiu

5 years ago

Thought provoking graphic. I would say that despite initial (healthy) debate, most of us in the lung cancer space are recommending adjuvant osimertinib where available. #LCSM #ASCO21

6 11 77 0 1

0 0 4 0 0

View Details

Subha Madhavan @subhamadhavan

5 years ago

@NCIDirector shares his opening remarks @ASCO #ASCO2021. Since 1990, there has been a 30% drop in cancer mortality due to behavior modifications like tobacco cessation and new/exciting drugs such as immunotherapies and targeted therapies.

0 0 0 0 0

View Details

Gerson Rolim @GersonRolim

5 years ago

The future of Clinical Trials: how #AI, #BigTech, & #Covid19 could make drug development cheaper, faster & more effective #DX #ML V/@CBinsights @GersonRolim @intellimetri cbinsights.com/research/clini… #100DaysOfCode #WomenWhoCode #100DaysOfMLCode #HealthTech #Coding #Chatbot #Python

0 24 16 0 0

View Details

Subha Madhavan @subhamadhavan

5 years ago

@lan24hd Sorry for your loss. Deepest condolences to all members of the family.

0 0 1 0 0

View Details

Subha Madhavan @subhamadhavan

5 years ago

@StephenVLiu @glenechopark This was my son’s favorite weekend spot many years ago. So excited to see that it continues to attract children.

0 0 1 0 0

View Details

Georgetown Health Informatics & Data Science @Georgetown_HIDS

5 years ago

Congratulations to @Georgetown_HIDS alumni Fuyuan Wang! He recently joined @FredNatLab subcontractor Essential Software as Software Engineer. Apply to our one year industry driven #HealthInformatics & #DataScience Masters Program. Deadline July 1st: lnkd.in/ejrdtg6

0 2 2 0 0

View Details

Mark Hoffman @markhoffmankc

5 years ago

Great #Nexusinformatics talk by @subhamadhavan describing virtual molecular tumor board.

0 2 8 0 0

View Details

Dennis Ridenour @DennisRidenour

5 years ago

Loving the first keynote from @subhamadhavan of @ICBI_Georgetown on Virtual Molecular Tumor Boards at the #NexusInformatics Conference with @BioNexusKC @ChildrensMercy @clevelandunivkc @KansasCityU

0 2 5 0 0

View Details

Subha Madhavan @subhamadhavan

5 years ago

@DShaywitz @timmermanreport Terrific post and Happy Sunday! Love the characterization of bilingual experts in data science and medical science. Would be interesting to see what opportunities are being seized by these experts in subsequent TR column.